Initiated in 1975, the Eberbach/Wiesloch Study is a prospective preventive study modeled after the Cardiovascular Comprehensive Community Central Programme of the WHO, with the aim of lowering the incidence of cardiac infarctions in a population representative of that of the Federal Republic of Germany. Part of the study is devoted to a description of smoking habits, and in particular, of the effect of cigarette smoking on plasma lipid and lipoprotein levels. Important components of this investigation were the inclusion of plasma levels of cotinine (a stable metabolite of nicotine and the only precise parameter of cigarette consumption), as well as the correlation of cotinine with other plasma parameters. Not only are these studies unique in the Federal Republic of Germany, but they also provide significant insight into the development of arteriosclerosis in connection with the established risk factors of smoking and hyperlipidemia. The data collected point to a considerable influence of smoking behavior on plasma lipid protein parameters.

The association of diabetes mellitus and hypertension has been well known for a long time. However, the important impact of hypertension on the development of chronic complications of diabetes and on the prognosis of the diabetic patient has only recently been realized. The increasing number of patients with endstage diabetic nephropathy who need regular dialysis or renal transplantation reflects only one important aspect of this problem. As new targets for the treatment of hypertension were considered, it became evident, that drug treatment of hypertension in diabetics must take side effects into account which may be negligible in the nondiabetic patient. Basic research has granted much new insight into the mechanisms which function to link diabetes, kidney function, hypertension, and vascular disease. As a result of the high specialisation in research, such new information diffuses only slowly out of the circles of experts into clinical practice. Therefore, it was a most rewarding initiative of the Bayer Company to sponsor a conference which aimed at a mutual exchange of ideas between clinicians and researchers who are experts in either hypertension or diabetes.

His scientific contributions are regarded as classics: the studies about the insulin effect on adipose tissue (together with George F. Cahill Jr. ), his work on the biosyn- thesis and secretion of insulin (together with Lelio Orci and Claes W ollheim) and his studies on various spontaneous and induced diabetes syndromes in rodents (together with Bernard Jeanrenaud and Eleazar Shafrir). Albert Renold will be remembered for a long time by all who knew him for his achievements, for his kindness and his humanity. We dedicate the Proceedings of this symposium to his memory. Werner Creutzfeldt Pierre Lefebvre G6ttingen Liege History and Philosophy of Bayer Pharmaceutical Research W. -D. Busse Fachbereich Forschung Pharma, Bayer AG, D-5600 Wuppertal, FRG Research has a long tradition at Bayer. This year, 1988, marks 100 years of our pharmaceutical activities. In 1888 the first Bayer drug - phenacetin, an antipyreti- was synthesized, starting from a by-product of dye manufacture. This finding led to the establishment of a Pharmaceutical Department within Friedrich Bayer and Co. in Elberfeld, with all its associated facilities (Fig. 1). The beginning of the company itself, however, dates back to 1863. In that year, Friedrich Bayer started the produc- tion of aniline dyestuffs in his private house in Barmen-Rittershausen. During the 125 years of the company's life and the 100 years of pharmaceuticals, many developments and products have been discovered by Bayer researchers and launched by Bayer.

Ideo autem omnes ad consilium vocari diximus, quia saepe iuniori Dominus revelat quod melius est. * Benedictus de Nursia Regula Benedicti, ca. 550 A. c. Caput III,3 The Wilsede Meetings were initiated in 1973 as an unusual experiment, and in the meantime this biennial symposium has already come to constitute an established and successful tradition. In June 1986 scientists and physicians met for the seventh time in the 3- year-old Emmenhof in Wilsede, in the heart of the Liineburg Heath, to dis- cuss modern trends in human leukemia. It was Pappenheim who in 1910 prepared the first international hematol- ogy congress. It was to have been held in Berlin under the title "Der groBe mononukleiire Leukozyt Ehrlichs, seine Morphologie und Funktion, seine Herkunft und seine Benennung" (Ehrlich's large mononuclear leukocyte. Its morphology, function, origin, and name), which was the most important and topical question at that time. It is amazing to think that as early as 1900, thanks to the pioneering research of Maximov and the innovative staining method developed by Ehrlich, the differentiation of the blood cells had, to a large extent, already been discovered. It is a sad fact that this congress never took place due to personal controversies among leading hematol- ogists, especially between Pappenheim and the Austrian hematologist Tiirk. Fortunately the Wilsede Meetings have never incurred this type of per- sonal controversies. On the contrary, both matter-of-fact discussions at a high scientific level and the development of personal friendships have always characterized their singular atmosphere.

Recent years have seen a greater industrial emphasis in undergraduate and postgraduate courses in the pharmaceutical and chemical sciences. However, textbooks have been slow to adapt, leaving the field without a text/reference that is both instructional and practical in the industrial setting - until now. A Handbook of Bioanalysis and Drug Metabolismis a stimulating new text that examines the techniques, methodology, and theory of bioanalysis, pharmacokinetics, and metabolism from the perspective of scientists with extensive professional experience in drug discovery and development. These three areas of research help drug developers to optimize the active component within potential drugs thereby increasing their effectiveness, and to provide safety and efficacy information required by regulators when granting a drug license. Professionals with extensive experience in drug discovery and development as well as specialized knowledge of the individual topics contributed to each chapter to create a current and well-credentialed text. It covers topics such as high performance liquid chromatography, protein binding, pharmacokinetics and drug-drug interactions. The unique industrial perspective helps to reinforce theory and develop valuable analytical and interpreting skills. This text is an invaluable guide to students in courses such as pharmaceutical science, pharmacology, chemistry, physiology and toxicology, as well as professionals in the biotechnology industry.

With contributions from 66 world-renowned authorities on the subject, Genomics And Proteomics In Nutrition focuses on the effect of genetic expression on protein production, establishing links between gene expression and nutrition, the influence of micro- and macronutrients on cellular homeostasis, and the relationship between diet, genetic predisposition, and human disease. Shows how bioinformatics and functional genomic databases can transform molecular biology research using a yeast ELO2/ human HELO1 protein cloning example. A cutting-edge reference, Genomics and Proteomics in Nutrition reveals new applications and insights in nutrition science and explores tools for nutrition research in the post-genomic era.

"Endocrine and Metabolic Disease" is in two sections. The first is a systematic review of clinical and therapeutic aspects of endocrine diseases, whilst the second considers the clinical pharmacology of drugs used in endocrinology. All the major areas of endocrinology and metabolism are covered. Thyroid, adrenal and pancreatic disease are discussed in depth and there are separate chapters on the ovary and testes as well as on the pituitary gland and parathyroids. There is a useful pharmacopoeia of drugs used in endocrinology at the end of the volume.

Symposium on Lipoprotein Metabolism, held in Heidelberg, September 10-13, 1975

Stellen Sie sich vor: Sie sind ein gestresster Manager und sollten Ihr Zeitproblem mit einer "Zeitdiat" in den Griff bekommen, also: in den nachsten Wochen moglichst wenig Zeit zu verbrauchen. Absurd?

"Blitzdiaten" sind genauso wirkungslos. Ernahrung begleitet uns standig und bedarf standiger Anpassung. Mit einem Blick aus der "KiloCoach-Perspektive" werden Sie erstaunliche Entdeckungen machen. Sie erfahren Wissenswertes uber den biologischen Vorteil, Fett zu speichern, uber effektive Zielverwirklichung bis hin zu konkreten Anleitungen zum erfolgreichen Abnehmen. Auch die genussvolle Seite des Essens kommt nicht zu kurz. Wer die neue Sichtweise gleich umsetzen will, kann auf der Kilocoach-Website sein eigenes Ernahrungsprotokoll fuhren und sich coachen lassen. Abnehmen und dauerhaftes Wunschgewicht sind kein Geheimnis, sondern ein realistisches Ziel fur jeden."

Vitamin D insufficiency/deficiency is a worldwide, public health problem in both developed and developing countries. Rickets among infants has reemerged. Low levels of vitamin D are associated with increased risk and mortality from cancer. At the same time, the beneficial effects of vitamin D on a host of conditions have recently been discovered. Focusing on areas not extensively covered in other comparable books, Vitamin D: Oxidative Stress, Immunity, and Aging highlights the most recent research findings on the impact of this nutrient in oxidative stress, immunity, and aging. A state-of-the-art compilation of essential information, this book explores: Vitamin D and its genomic and nongenomic effects, the role of therapeutic analogs in treating disease, and the production of vitamin D by the body The role vitamin D plays in modulating oxidative stress-with emphasis on cancer, stress-mediated diseases, photo-protection of the skin, and energy metabolism Beneficial effects of vitamin D in regulating the immune response and its importance in protecting against autoimmune, infectious, and inflammatory diseases The role vitamin D plays in the regulation of the aging process-including aspects of oxidative stress, senescence, and mortality, as well as its role in protection against cardiovascular disease and nervous system disorders This book represents an important contribution toward understanding the mechanisms by which vitamin D promotes health, increasing awareness of the importance that vitamin D plays during development, at birth, and throughout the aging process. It is a valuable reference for researchers in academia, nutrition, medicine, and industry.

Das Buch hebt auch in der 2. komplett uberarbeiteten und aktualisierten Auflage den interdisziplinaren Charakter der Behandlung des diabetischen Fusssyndroms hervor. Nur in einem ausgewogenen Zusammenspiel von operativ und nicht-operativ tatigen AErzten sowie den entsprechenden medizinischen Assistenzberufen ist eine umfassende und die Extremitat erhaltende Therapie moeglich. Die Umsetzung des Gelesenen in die Praxis erleichtern die therapeutischen Algorithmen und die vielen Handlungsempfehlungen, die die Autoren geben. Zahlreiche Abbildungen/Bildserien veranschaulichen daruber hinaus die Inhalte.

Die vergessene Alternative zur aufwendigen Arzneitherapie! In diesem Buch erfahren Sie alles Wissenswerte uber die erfolgreiche Behandlung von Erkrankungen mit Hilfe der Ernahrungstherapie. Die Vorzuge gegenuber der herkoemmlichen Arzneitherapie liegen auf der Hand: Sie ist risikoarm, effizient, kostengunstig und vor allem hat der Patient keinerlei Nebenwirkungen zu befurchten. Dieses Kompendium gibt praxisbezogene Ernahrungstipps zu einem grossen Spektrum von Krankheiten, wie zum Beispiel bei Cholesterinproblemen, koronarer Herzkrankheit, Bluthochdruck, Diabetes mellitus und Krebs. Der Inhalt basiert auf jahrzehntelanger diatetischer Erfahrung grosser Kliniken. Alphabetisch geordnete Stichwoerter bieten dem Arzt, der Diatassistentin und der OEkotrophologin einen schnellen Zugriff auf Informationen zu annahernd 600 Krankheitsbildern aus allen Fachgebieten der Medizin. Jetzt als vollstandig uberarbeitete und erweiterte Neuauflage!

The Nutrition and Health series of books have had great success because each volume has the consistent overriding mission of providing health professionals with texts that are essential because each includes (1) a synthesis of the state of the science, (2) timely, in-depth reviews by the leading researchers in their respective ?elds, (3) extensive, up-to-date fully annotated ref- ence lists, (4) a detailed index, (5) relevant tables and ?gures, (6) identi?cation of paradigm shifts and the consequences, (7) virtually no overlap of information between chapters, but targeted, inter-chapter referrals, (8) suggestions of areas for future research, and (9) balanced, data-driven answers to patient as well as health professionals questions which are based upon the totality of evidence rather than the ?ndings of any single study. The series volumes are not the outcome of a symposium. Rather, each editor has the potential to examine a chosen area with a broad perspective, both in subject matter and in the choice of chapter authors. The editor(s), whose training(s) is (are) both research and practice oriented, has(ve) the opportunity to develop a primary objective for their book, de?ne the scope and focus, and then invite the leading authorities to be part of their initiative. The authors are encouraged to provide an overview of the ?eld, discuss their own research, and relate the research ?ndings to potential human health consequences.

Whether you are following a problem-based, an integrated or a more traditional medical course, clinical biochemistry is often viewed as one of the more challenging subjects to grasp. What you need is a single resource that not only explains the biochemical underpinnings of metabolic medicine, but also integrates laboratory findings with clinical practice. You will find all this, and more, in the eighth edition of Clinical Biochemistry and Metabolic Medicine. This well-respected text provides comprehensive and measured guidance to this complex area, reflecting the ongoing changes in our understanding of clinical biochemistry while preserving the acknowledged strenghths of previous editions: readability, a firm basis in the underlying science and a clear focus on clinical applicability.

Functional Biochemistry in Health and Disease provides a clear and straightforward account of the biochemistry that is necessary to understand the physiological functions of tissues or organs essential to the life of human beings. Focusing on the dynamic aspects of biochemistry and its application to the basic functions of the body, the book bridges the gap between biochemistry and medical practice.

Carefully structured within five sections, each biochemical, physiological or medical subject that is covered in the book is presented in one complete chapter. Consequently, each subject can be read and studied in isolation although cross-sectional links between the subjects are included where necessary. Background material, both biochemical and medical, that is necessary for an understanding of the subject, is included at the start of each chapter and clear, relevant diagrams enhance students' understanding.Focuses on medically relevant aspects of biochemistry written from a physiological rather than a chemical perspective.Clear presentation that minimises the use of jargon.Each chapter contains boxes on related topics, relevant diagrams and a brief glossary.Coverage includes athletic performance, apoptosis and the immune system.Key historical developments are included to show how modern biochemistry has evolved.

By linking biochemistry, medical education and clinical practice this book will prove invaluable to students in medical and health sciences, biomedical science and human biology taking an introductory biochemistry course. In addition it will appeal to biochemistry and biology students interested in clinical applications of biochemistry.

Since the birth of the dietary fibre hypothesis in the early 1970's, research on this topic has been growing rapidly. However, though the remarkable number of experimental works, the role of fibre on human health is still uncompletely understood. The objective of this book is to synthesise the current knowledge on the physiological effects of dietary fibre in man by focusing on the mechanisms of action.

Endocrine Disruption and Human Health starts with an overview of what endocrine disruptors are, the issues surrounding them, and the source of these chemicals in the ecosystem. This is followed by an overview of the mechanisms of action and assay systems. The third section includes chapters written by specialists on different aspects of concern for the effects of endocrine disruption on human health. Finally, the authors consider the risk assessment of endocrine disruptors and the pertinent regulation developed by the EU, the US FDA, as well as REACH and NGOs. The book has been written for researchers and research clinicians interested in learning about the actions of endocrine disruptors and current evidence justifying concerns for human health but is useful for those approaching the subject for the first time, graduate students, and advanced undergraduate students.

Texts on inborn errors of metabolism (IEMs) have traditionally focused on classical biochemistry, clinical presentation, and standard treatment approaches. Inborn Errors of Metabolism is an expansion on this model, one that establishes an innovative pathway approach and provides a new authority on this family of disease.
Alongside the standard cadre of molecular and clinical underpinnings, this volume includes coverage of newborn screenings and an overarching treatment of IEMs as complex diseases -- how basic alterations can lead to complex secondary and tertiary effects in metabolism that contribute to increasingly recognized natural histories of disease.

Metabolism at a Glance presents a concise, illustrated summary of metabolism in health and disease. This essential text is progressively appropriate for introductory through to advanced medical and biochemistry courses. It also provides a succinct review of inborn errors of metabolism, and reference for postgraduate medical practitioners and biomedical scientists who need a resource to quickly refresh their knowledge. Fully updated and extensively illustrated, this new edition of Metabolism at a Glance is now in full colour throughout, and includes new coverage of sports biochemistry; the metabolism of lipids, carbohydrates and cholesterol; glyceroneogenesis, -oxidation and -oxidation of fatty acids. It also features the overlooked Krebs Uric Acid Cycle . Metabolism at a Glance offers an accessible introduction to metabolism, and is ideal as a revision aid for students preparing for undergraduate and USMLE Step 1 exams.

Lysosomal storage diseases are inherited metabolic disorders characterized by severe pathology, typically involving the brain. Although individually rare, they collectively represent a significant group of diseases that primarily present in early infancy or childhood. In recent years considerable progress has been made in understanding the molecular mechanisms that lead to disordered function of the lysosomal system and to lysosomal storage. Unravelling the basis for these diseases is providing unique insight into the normal biology of cells and pointing the way to the development of therapeutic strategies for their treatment.

Lysosomal Disorders of Brain details recent advances in the molecular and cellular pathologies of these diseases and in the development of effective therapies. After an overview of the biology of the endosomal-lysosomal system and the types of diseases resulting from defects in this system, the book describes in detail the molecular mechanisms of storage, model systems and pathophysiological mechanisms, and finally, new advances toward treatment. With each chapter written by leading experts in their field, this book will be valuable for scientists and clinicians in helping them understand the role of lysosomes in normal cells and mechanisms underlying these disorders, how they can be diagnosed, and the treatment options that are currently available.

This book will provide readers with up-to-date information on thyroid diseases, obesity and metabolic syndrome. The innovative element is the presentation and exploration of possible connections linking thyroid diseases and metabolism dysfunction. Starting from the classification and diagnosis of thyroid diseases, obesity and metabolic syndrome, techniques to study and treat each of the mentioned diseases are given in an easy-to-use way. This volume will be a useful tool for endocrinologists, diabetologists, dieticians, and any professionals involved in the treatment of thyroid diseases.

This is the first comprehensive volume to look at the importance of short-chain fatty acids in digestion, the function of the large intestine and their role in human health. Short-chain fatty acids are the major product of bacterial fermentation of dietary carbohydrates in the human and animal large intestine. Through their absorption from the caecum and colon they provide a means whereby energy can be salvaged from carbohydrates not digested in the upper gut. It is now increasingly recognized that they may have a significant role in protecting against large-bowel diseases and in metabolism in other tissues. This volume has been prepared by an international team of contributors who are at the forefront of this area of research. The volume will be an essential source of reference for gastroenterologists, nutritionists and others active in this area.